Clinical trial · Interventional
Roadmap to Parenthood: Testing the Efficacy of a Decision Aid and Planning Tool for Family Building After Cancer
NCT06050135CI-TRIAL-00104038active not recruitingN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will test a decision support intervention that consists of a web-based 'decision aid and planning tool' for family building after cancer in a randomized controlled trial.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Parenthood Status | — | UNRESOLVED | — |
| Quality of Life | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Informational Booklet | Other | — | UNRESOLVED |
| Roadmap to Parenthood | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Web-based decision support (Roadmap to Parenthood)
- description
- Patients will receive access to the Roadmap to Parenthood tool (website). The goal of the Roadmap tool is to encourage young adult females (YA-Fs) to be informed about family-building options, set realistic expectations about potential difficulties, and plan ahead to avoid or mitigate barriers, while also inspiring hope and confidence that parenthood may be achieved, despite their cancer histories.
- interventionNames
- Other: Roadmap to Parenthood
- type
- ACTIVE_COMPARATOR
- label
- Informational booklet
- description
- Patients will receive the web-based Livestrong 'Planning for Life After Cancer: A Guide to Survivorship for Teens and Young Adults' informational booklet, covering many topics (e.g., physical symptoms, emotional concerns, day-to-day needs).
- interventionNames
- Other: Informational Booklet
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
- Maximum age
- 45 Years
Show eligibility criteria text
Inclusion Criteria: * Assigned female at birth * Aged 18 to 45 years old * Understands verbal and written English * History of a cancer diagnosis. * Completed cancer treatment(s) with known or uncertain gonadotoxic effects (e.g., systemic chemotherapy, surgery or radiation affecting reproductive organs or hormone regulation, stem cell or bone marrow transplant, and/or immunotherapy) * Interested in having a future child (or more children) or uncertain about family building plans * Access to the Internet and use of a computer, tablet, or smartphone * Ability to understand and the willingness to personally sign the written IRB-approved informed consent document Exclusion Criteria: * Currently undergoing cancer treatment excluding long term adjuvant or maintenance therapies, such as tamoxifen * Significant physical or mental disability that prevents completion of study activities
References
Publications (0)
Data not yet available
No reference posted for this study.